Please take special note that the Major Modifications for 2022 include the following: 1
5 A 2024 study suggests that semaglutide (GLP-1 RA) drugs may lower your cravings for sweet foods by improving taste sensitivity, changing the gene expression on your tongue thats responsible for taste perception, and even changing the way your brain responds to sweet tastes
The drug does not target your muscle
However, because they are not FDA-approved, there are risks and questions about their consistency and effectiveness that patients should be aware of before committing
Once you add water during reconstitution, those reactions restart
At our Manhattan practice, were seeing increasing numbers of patients using GLP-1 medications, often without realizing the potential impact these medications can have on mood, anxiety, and overall psychological wellbeing